Orthofix Medical Inc is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The company has four reportable segments include Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. It generates maximum revenue from Bone Growth Therapies segment. Geographically, it generates maximum revenue from a company the U.S and also has a presence in Italy, Germany, United Kingdom, Brazil, and other countries.
| Website: | www.orthofix.com |
| Email: | markquick@orthofix.com |
| Main Phone: | +1 214 937-2000 |
| Address: | 3451 Plano Parkway |
| State: | TX |
| City / Town: | Lewisville |
| Country: | USA |
| Postal Code: | 75056 |
| Exchange: | NGS |
| CEO: | Jon Carl Serbousek |
| Employees: | 1055 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
The world of small-cap health care companies is a familiar one, right? Small biotech and pharma companies have promising drugs in their pipeline, not profits or revenues. It’s just
Yesterday, the market answered my question, “Are Bulls Tiring ?” with a solid rise, repeating a pattern of extreme intraday volatility that has run the DJIA up and down 200 points nine times
Orthofix Medical Inc is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The company has four reportable segments include Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. It generates maximum revenue from Bone Growth Therapies segment. Geographically, it generates maximum revenue from a company the U.S and also has a presence in Italy, Germany, United Kingdom, Brazil, and other countries.
| Website: | www.orthofix.com |
| Email: | markquick@orthofix.com |
| Main Phone: | +1 214 937-2000 |
| Address: | 3451 Plano Parkway |
| State: | TX |
| City / Town: | Lewisville |
| Country: | USA |
| Postal Code: | 75056 |
| Exchange: | NGS |
| CEO: | Jon Carl Serbousek |
| Employees: | 1055 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
The world of small-cap health care companies is a familiar one, right? Small biotech and pharma companies have promising drugs in their pipeline, not profits or revenues. It’s just
Yesterday, the market answered my question, “Are Bulls Tiring ?” with a solid rise, repeating a pattern of extreme intraday volatility that has run the DJIA up and down 200 points nine times
| Last Price 29.68 | Change $ -0.66 | Change % -2.18 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 30.08 | High 30.28 | Low 28.99 | Prev Close 30.34 |
| Last Trade | Volume 114,169 | 52 Wk Hi 55.17 | 52 Wk Low 22.12 |
| Market Cap 569.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 19,202,587.00 | EPS (TTM) -0.23 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 9 | 37 |
| Number of Buys | 9 | 26 |
| Number of Sells | 0 | 11 |
| Net Activity | 48070 | 67650 |
| Last 10 Buys | Shares |
|---|---|
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| James Hinrichs | 1,000 |
| Mark A. Heggestad | 1,000 |
| Emily Buxton | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Brad Niemann | 1,000 |
| Bradley R. Mason | 1,000 |
| Luke T. Faulstick | 1,000 |
| Doug Rice | 1,000 |
| Brad Niemann | 1,000 |
| Bradley R. Mason | 1,000 |
| Raymond Fujikawa | 1,000 |
| Bradley R. Mason | 1,000 |
| Bradley R. Mason | 1,000 |
| Michael M. Finegan | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 72 | 72 | 72 | 72 |
| Low Target Price Estimate | 52 | 52 | 52 | 52 |
| Mean Target Price Estimate | 63.6 | 64 | 64 | 63.6 |
| Standard Deviation | 7.54 | 8.64 | 8.64 | 7.54 |
| Date of Most Recent Estimate | 06/01/18 | 05/24/18 | 05/02/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-15 |
| SD | Specialized Disclosure Report | 6 | 2018-05-30 |
| 424B3 | Prospectus filed under Rule 424(b)(3) | 184 | 2018-05-30 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2018-05-29 |
| S-4/A | Pre-effective amendment to an S-4 filing | 195 | 2018-05-24 |
| 8-K/A | Amendment to a previously filed 8-K | 43 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| S-8 | Securities offered to employees under employee benefit plans | 47 | 2018-04-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 165 | 2018-04-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 13 | 2018-04-30 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait